Swedish Probi and healthcare company BIO-LIFE have signed a partnership agreement for the launch of a probiotic product in Asia.
PROBI and BiO-LiFE have signed a long term agreement to partner for the branding and launch of Probi’s Lactobacillus plantarum 299v. BiO-LiFE, a growing healthcare subsidiary within DKSH, will according to the agreement provide co-branding, product launch services, sales, marketing and technical services in the local market. The product will be marketed in a cobranded solution with BiO-LiFE and PROBI LP299V. It is positioned against Irritable Bowel Syndrome (IBS) symptoms like abdominal pain, bloating, constipation and flatulence.
The plan is to launch the product in Malaysia during the second half of 2013 and with the intention to extend into other countries in South East Asia.